P

Inventor

MURPHY ANDREW J

US349 patents
⚠️ This page may combine multiple inventors who share the name “MURPHY ANDREW J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REGENERON PHARMA

39 patents
US9987500B2Jun 5, 2018

Human antibodies to PD-1

REGENERON PHARMA126 citations99
US9006511B2Apr 14, 2015

Human lambda light chain mice

REGENERON PHARMA45 citations99
US8697940B2Apr 15, 2014

ADAM6 mice

REGENERON PHARMA114 citations99
US7105348B2Sep 12, 2006

Methods of modifying eukaryotic cells

REGENERON PHARMA355 citations99
US6596541B2Jul 22, 2003

Methods of modifying eukaryotic cells

REGENERON PHARMA996 citations99
US6586251B2Jul 1, 2003

Methods of modifying eukaryotic cells

REGENERON PHARMA505 citations99
US10412940B2Sep 17, 2019

Mice expressing a limited immunoglobulin light chain repertoire

REGENERON PHARMA38 citations98
US9932408B2Apr 3, 2018

ADAM6 mice

REGENERON PHARMA22 citations98
US9540449B2Jan 10, 2017

Anti-PCSK9 antibodies with pH-dependent binding characteristics

REGENERON PHARMA57 citations98
US9453072B2Sep 27, 2016

Anti-IL-33 antibodies

REGENERON PHARMA49 citations98
US9226484B2Jan 5, 2016

Human lambda light chain mice

REGENERON PHARMA31 citations98
US9206263B2Dec 8, 2015

Method of making antibodies using a human lambda light chain mouse

REGENERON PHARMA33 citations98
US9163092B2Oct 20, 2015

Hybrid light chain mice

REGENERON PHARMA36 citations98
US9150662B2Oct 6, 2015

Hybrid light chain mice

REGENERON PHARMA31 citations98
US9079948B2Jul 14, 2015

Human antibodies to Fel d1 and methods of use thereof

REGENERON PHARMA83 citations98
US9066502B2Jun 30, 2015

Hybrid light chain mice

REGENERON PHARMA36 citations98
US9029628B2May 12, 2015

Human lambda light chain mice

REGENERON PHARMA37 citations98
US8847005B2Sep 30, 2014

Genetically modified major histocompatibility complex mice

REGENERON PHARMA33 citations98
US9637535B2May 2, 2017

IL-33 antagonists and uses thereof

REGENERON PHARMA36 citations97
US9462794B2Oct 11, 2016

Non-human animals having a humanized signal-regulatory protein gene

REGENERON PHARMA28 citations97
US9193977B2Nov 24, 2015

Non-human animals having a humanized signal-regulatory protein gene

REGENERON PHARMA29 citations97
US9127292B2Sep 8, 2015

Non-human animals having a humanized signal-regulatory protein gene

REGENERON PHARMA28 citations97
US9113616B2Aug 25, 2015

Genetically modified mice having humanized TCR variable genes

REGENERON PHARMA67 citations97
US8878001B2Nov 4, 2014

Humanized IL-6 and IL-6 receptor

REGENERON PHARMA38 citations97
US9206262B2Dec 8, 2015

Method of cloning a lambda light chain variable domain using a human lambda light chain mouse

REGENERON PHARMA20 citations96
US9206261B2Dec 8, 2015

Method of making antibodies using a human lambda light chain mouse

REGENERON PHARMA19 citations96
US10905109B2Feb 2, 2021

ADAM6 mice

REGENERON PHARMA10 citations94
US10694725B2Jun 30, 2020

ADAM6 mice

REGENERON PHARMA15 citations94
US10577430B2Mar 3, 2020

ADAM6 mice

REGENERON PHARMA15 citations94
US10561124B2Feb 18, 2020

Humanized light chain mice

REGENERON PHARMA12 citations94
US9944716B2Apr 17, 2018

ADAM6 mice

REGENERON PHARMA17 citations94
US9938345B2Apr 10, 2018

Human antibodies to PD-L1

REGENERON PHARMA37 citations94
US9796788B2Oct 24, 2017

Mice expressing a limited immunoglobulin light chain repertoire

REGENERON PHARMA26 citations94
US9334334B2May 10, 2016

Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same

REGENERON PHARMA31 citations94
US9301510B2Apr 5, 2016

Mice that produce antigen-binding proteins with pH-dependent binding characteristics

REGENERON PHARMA28 citations94
US9204624B2Dec 8, 2015

Non-human animals with modifed immunoglobulin heavy chain sequences

REGENERON PHARMA30 citations94
US9043996B2Jun 2, 2015

Genetically modified major histocompatibility complex animals

REGENERON PHARMA31 citations94
US10676530B2Jun 9, 2020

Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor

REGENERON PHARMA14 citations93
US10669341B2Jun 2, 2020

Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor

REGENERON PHARMA13 citations93

MACDONALD LYNN

4 patents

MURPHY ANDREW J

2 patents

CADUS PHARMACEUTICAL CORP

2 patents

SLEEMAN MARK W

1 patent

STEVENS SEAN

1 patent

ECONOMIDES ARIS N

1 patent

Showing the top 50 of 349 patents by PatentIndex Score.